The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of pembrolizumab in combination with mFOLFOX6 for patients with advanced colorectal cancer.
 
Safi Shahda
Consulting or Advisory Role - Merrimack
Research Funding - Myriad Genetics
 
Anne M. Noonan
Consulting or Advisory Role - Helsinn Healthcare
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Glenmark; Lilly; Merrimack; NCCN; Regeneron; Research to Practice; Taiho Pharmaceutical
Research Funding - NCCN; NCI; Oncolytics
Expert Testimony - Helsinn Therapeutics
Other Relationship - ARMO BioSciences; Exelixis; Exelixis; Merck; Polaris; Sillajen
 
Bert H. O'Neil
Consulting or Advisory Role - Amgen; Bayer; Genentech/Roche; Lilly/ImClone
Travel, Accommodations, Expenses - Merck KGaA
 
Amikar Sehdev
Consulting or Advisory Role - Gerson Lehrman Group
 
Walid Labib Shaib
No Relationships to Disclose
 
Paul R. Helft
Honoraria - Genentech
Consulting or Advisory Role - Genentech
 
Patrick J. Loehrer
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - US PPA/61/499,988 Gene Expression Analysis of Thymic Neoplasms Inventors: Sunil Badve, Yesim Gokmen-Polar, Patrick Loehrer (Inst)
 
Yan Tong
No Relationships to Disclose
 
Ziyue Liu
No Relationships to Disclose
 
Bassel F. El-Rayes
Consulting or Advisory Role - BTG; Genentech/Roche; Merrimack; Merrimack
Research Funding - AVEO (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); Novartis (Inst); Pfizer (Inst); PPD (Inst); Taiho Pharmaceutical (Inst)